Articles by R. Christian Moreton - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by R. Christian Moreton

R. Christian Moreton

vice-president, pharmaceutical sciences

R. Christian Moreton, PhD, is vice-president of pharmaceutical sciences at Finnbrit Consulting and a member of Pharmaceutical Technologys editorial advisory board.

Toward Expanding Understanding
March 2, 2011

A revised book on process analytical technology could be valuable to novices and experts.

Flexible Approaches to Accommodate Excipient Variability Using the Principles of QbD
May 1, 2010

The authors review new regulatory expectations and describe potential approaches to accommodate excipient variability. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010."

The Continuing Story of Nanoparticles
November 2, 2007

A book illustrates the potential for nanoparticulate drug delivery, and how much about them remains to be understood.

Manufacturing One Trend at a Time
October 2, 2007

Change is inevitable, as is contract manufacturing. But which companies will survive the drifts?

Functionality and Performance of Excipients
October 1, 2006

This article provides an overview of functionality, functionality-related characteristics, and excipients performance.

Excipient Functionality
May 2, 2004

The author suggests that an excipient's functionality can only be determined in the context of a specific formulation and manufacturing process.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here